tenofovir has been researched along with Chronic Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezquerra-Durán, A; García-Buey, L; Gutiérrez-Cobos, A | 1 |
| Andreoletti, L; Bani-Sadr, F; Gatouillat, G; Gordien, E; Hentzien, M; N'Guyen, Y; Yaici, L | 1 |
2 other study(ies) available for tenofovir and Chronic Hepatitis
| Article | Year |
|---|---|
Healing of chronic hepatitis delta relapsing to pegylated interferon with tenofovir.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis, Chronic; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Tenofovir; Treatment Outcome | 2022 |
Chronic hepatitis delta cirrhosis cured by adapting PEG-IFNα-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss.
Topics: Antiviral Agents; DNA, Viral; Duration of Therapy; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis D, Chronic; Hepatitis, Chronic; Humans; Liver Cirrhosis; Tenofovir; Treatment Outcome | 2023 |